On Tuesday, Mar. 20 2011, the U.S. Supreme delivered its ruling in Mayo Collaborative Services, dba Mayo Medical Laboratories, et al. v.

On Tuesday, Mar. 20 2011, the U.S. Supreme delivered its ruling in Mayo Collaborative Services, dba Mayo Medical Laboratories, et al. v.
On October 12, 2011, the American Civil Liberties Union and the Patent Protection Foundation announced their decision to petition the Supreme Court for certiorari after its Federal Circuit rehearing petition for Association for Molecular Pathology v. U.S.
Earlier this month the Agriculture Department (USDA) announced that American farmers are allowed to resume growing genetically modified sugar beets.
On December 16 of last year, President Obama’s Commission for the study of Bioethical Issues released its findings regarding the adequacy of current federal regulations over the field of Synthetic Biology (“SynBio”). On the exact same day, 58 NGOs sent a Read more ...
A Canadian company recently asked the US Dept. of Agriculture (USDA) to approve a genetically modified apple that won’t turn brown when bitten or sliced into. Okanagan Specialty Fruits petitioned the Animal and Plant Health Inspection Service (APHIS), a service within the USDA, with approval still pending.
For most intents and purposes, brand-name drug manufacturers (“pioneers”) and generic drug manufacturers (“generics”) are strictly competitors, just like competitors in any other section of the market place. However, FDA regulations have created a reality where in at least one aspect of their business, pioneers and generics have their wagons hitched to the same horse. All manufacturers of a particular drug must use the same substantive warning which has been Read more ...
With cars capable of achieving zero emissions (see the Tesla Roadster and the Honda FCX Clarity), one cannot help but wonder why this technology has not transferred to heavy-duty combination tractors. Such tractors, which are commonly known as semis, normally attain six miles per gallon yet are accountable for twenty percent of all vehicle fuel consumed.
Last week, the U.S. Department of Justice (DOJ) weighed in on current controversial litigation involving gene patents by filing an amicus curiae brief (pdf) in the appeal of the Myriad case (Association for Molecular Pathology v. U.S. Patent and Trademark Office).
On October 12, the Supreme Court heard Bruesewitz v. Wyeth, a case involving a 19-year-old girl who suffered seizures as an infant and who has consequently suffered developmental problems. The culprit? The DTP vaccine intended to protect against the potentially deadly childhood diseases of diphtheria, tetanus, and pertussis.